Semaglutide
Chronic weight management and other labeled uses vary by product
Evidence: Strong FDA-reviewed clinical evidence
Administration: Injection or oral; product-specific
Score 9.1/10Read Review →Evidence and regulatory context for peptide-based treatments connected to general education.
Tirzepatide
Chronic weight management; other indications depend on product
Evidence: Strong FDA-reviewed clinical evidence
Administration: Weekly injection
Score 9.1/10Read Review →Liraglutide
Weight management or type 2 diabetes, depending on product
Evidence: Strong FDA-reviewed clinical evidence
Administration: Daily injection
Score 8.7/10Read Review →Teriparatide
Osteoporosis in selected high-risk patients
Evidence: Strong FDA-reviewed clinical evidence
Administration: Daily injection
Score 8.6/10Read Review →Abaloparatide
Osteoporosis in selected high-risk patients
Evidence: Strong FDA-reviewed clinical evidence
Administration: Daily injection
Score 8.3/10Read Review →Glucagon
Emergency treatment of severe hypoglycemia
Evidence: Strong product-specific evidence
Administration: Nasal or injection; product-specific
Score 9.1/10Read Review →BPC-157
Investigational; no FDA-approved therapeutic indication
Evidence: Insufficient human evidence
Administration: No approved route
Read Review →TB-500
Investigational; no FDA-approved therapeutic indication
Evidence: Very limited human evidence
Administration: No approved route
Read Review →MOTS-C
Investigational metabolic and longevity research
Evidence: Primarily preclinical
Administration: No approved route
Read Review →CJC-1295
Investigational hormonal and body-composition research
Evidence: Limited clinical data
Administration: No approved route
Read Review →Ipamorelin
Investigational hormonal and body-composition research
Evidence: Limited human trials
Administration: No approved route
Read Review →Established / approved options
Start with product-specific FDA status, intended use, evidence quality, risks, and clinician requirements.
Being researched
Research compounds are shown for education with unmistakable unapproved status and no purchase or self-administration guidance.
How to use this page
Established options appear before experimental compounds. Goal relevance never overrides regulatory status or evidence quality.
Next step
Open the relevant treatment review for sources, risks, contraindications, and evidence gaps.
MyPeptideQuest
Information only. Not medical advice. No dosing or self-treatment instructions are provided.